Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
Danimer Scientific, Inc. incurred revolving credit of $20,000,000 with ABL OPCO LLC (d/b/a Mountain Ridge Capital) at SOFR market index rate plus an applicable margin of 7.0% maturing April 19, 2027.
- Instrument
- revolving credit
- Principal
- $20,000,000
- Counterparty
- ABL OPCO LLC (d/b/a Mountain Ridge Capital)
- Rate
- SOFR market index rate plus an applicable margin of 7.0%
- Maturity
- April 19, 2027
- Event
- incurrence
Exact text from the filing
The Credit Agreement provides for borrowings under a revolving commitment of $20,000,000
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Danimer Scientific, Inc. entered into Credit Agreement with ABL OPCO LLC (d/b/a Mountain Ridge Capital) valued at $20,000,000 (effective 2024-04-19).
- Action
- entry
- Agreement
- credit facility
- Counterparty
- ABL OPCO LLC (d/b/a Mountain Ridge Capital)
- Value
- $20,000,000
- Effective
- 2024-04-19
Exact text from the filing
On April 19, 2024, Danimer Scientific, Inc., Meredian Holdings Group, Inc., Danimer Scientific Holdings, LLC, Meredian, Inc., Danimer Scientific, L.L.C., Danimer Bioplastics, Inc., and Danimer Scientific Kentucky, Inc., (collectively, the “Borrowers”) and the other loan parties party thereto from time to time, entered into an asset-based Credit and Security Agreement (the “Credit Agreement”) with the financial institutions party thereto from time to time (the “Lenders”) and ABL OPCO LLC (d/b/a Mountain Ridge Capital) in its capacity as administrative agent for the Lenders (together with its successors and assigns in such capacity, the “Administrative Agent”).
View on SEC.gov